A local sympathetic-immune axis inhibits melanoma growth in mice by dictating adrenergic control.
| Publication Type | Academic Article |
| Authors | Liu T, Kutsovsky D, Earlie E, Ji L, Iskols M, Ramsamooj S, Dawkins X, Zerhouni M, Birbrair A, Piskounova E, Li M, Laughney A, Simon D |
| Journal | Neuron |
| Volume | 114 |
| Issue | 9 |
| Pagination | 1576-1593.e8 |
| Date Published | 04/29/2026 |
| ISSN | 1097-4199 |
| Keywords | Sympathetic Nervous System, Receptors, Adrenergic, alpha-2, Skin Neoplasms, Melanoma, Receptors, Adrenergic, beta, Melanoma, Experimental |
| Abstract | The nervous system drives tumor growth directly through intra-tumoral axons and indirectly through the systemic action of hormones. Yet contexts where the nervous system inhibits tumor growth are less defined. Here, we performed optical reconstruction of axonal innervation in mouse models of cutaneous melanoma, revealing progressive innervation by sympathetic axons. Local depletion of these axons accelerates while local optogenetic activation slows melanoma growth, together consistent with these axons acting as a physiological growth brake. The sympathetic nervous system is typically associated with driving tumor growth through activation of β-adrenergic receptors (ARs). Here, we find that the initial tumor seeding conditions sensitize melanomas from βAR-driven growth promotion toward α2-AR-driven growth inhibition. Mechanistically, the axonal activation of α2 ARs restricts the number and distribution of pro-tumor myeloid cells, independently of T cell activity. Together, our data reveal context-dependent, bidirectional neural control of tumor progression. |
| DOI | 10.1016/j.neuron.2026.04.016 |
| PubMed ID | 42061411 |
| PubMed Central ID | PMC13220253 |